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Sodium-potassium ATPase (Na, K-ATPase) is an integral protein universally distributed in the plasma membrane of all 
eukaryotic cells. It regulates trans-epithelial sodium ion transport, muscle contraction, nerve excitability, secretary functions 
and intracellular signaling. We investigated the mechanism of vasorelaxation effect of Eugenol, Curcumin and 
Nanocurcumin in the middle uterine artery (MUA) of goat to evaluate their possible therapeutic potential in hypertension 
during pregnancy or pre-eclampsia. The UA rings were isometrically contracted by K+-free MKHS to plateau and relaxed 
with KCl (10 μM-10 mM) following standard protocol. The K+ -vasorelaxation response (VR) was taken either in presence 
of ouabain with or without Eugenol/Curcumin/Nanocurcumin (10 μM). Rmax (maximum % vasorelaxation) of K
+-induced 
VR-curve elicited in UA rings was reduced (from 6.90% and 26.55%) to 4-5% in presence of Ouabain in both NP and P 
goats. Rmax obtained from KVR curve elicited in UA rings were augmented in presence of Eugenol (NP: 16.22%, P: 42.67%) 
or Curcumin (NP:21.23%, P:35.49%) or Nanocurcumin (NP:6.91%, P:34.88%). K+ vasorelaxation was inhibited in presence 
of Ouabain and Eugenol/ Curcumin/Nanocurcumin (Rmax: 6.11%, 9.18%, 4.11% in non-P, respectively) and (Rmax: 5.40%, 
3.39%, 6.00% in P, respectively). The results indicated that (i) there is increased function of α1- Na
+, K+-ATPase in UA of 
P goats (ii) Eugenol, Curcumin and Nano-curcumin differentially augmented the function and expression of α1 isoenzymes 
of sodium pump in UA of non-P and P goats. Thus, the polyphenols potentially activate α1 isoenzymes of Na
+-K+-ATPase 
and could possibly be useful as therapeutic in hypertension during pregnancy. 
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Na+, K+-ATPase is an electrogenic, heterodimeric 
transmembrane protein that regulates sodium pumps 
and cell signalling1. It plays a vital role in generation of 
electrochemical gradient through the cell membrane by 
pumping out 3 Na+ and influx of 2 K+ ions besides 
maintenance of cellular homeostasis2. The 
vasorelaxation induced by vascular sodium pump plays 
a pivotal role in regulation of membrane potential and 
smooth muscle tone in different vascular tissues3. The 
regulation of this enzyme functional activity and 
expression is substantially influenced by gender4, 
species5, sex and tissue location6,7. The endothelium 
dependent vascular sodium pump has been reported in 
human placental vessels8, rabbit aorta9, mice femoral 
artery10 and rat aorta11, goat mesenteric artery12 and 
endothelium independent in goat ruminal artery13.  
Nutraceuticals such as Eugenol and Curcumin, 
demonstrated to be useful in several health disorders 
including hypertension14-17. Due to their pleotropic 
action, several cellular and molecular targets have been 
proposed in variety of experimental models and cell 
lines. During pregnancy hypertension is a major concern 
in certain conditions like preeclampsia. Eugenol, 
Curcumin and Nanocurcumin could be the safest 
nutraceuticals to induce uterine artery vasodilation to 
facilitate maternal blood flow to foetus thus assist in 
maintenance of normal maternal blood pressure. With 
this hypothesis we examined their capability to increase 
the vascular Na+ pump activity, an important mediator of 
vasorelaxation. Eugenol is the active component of 
cloves (Syzygium aromaticum) and curcumin is obtained 
from turmeric (Curcuma longa) (Fig. 1 & Fig. 2). 
Eugenol is commonly used as flavouring agent, in 
preparation of cosmetics and as anaesthetic in dentistry. 
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It is widely used in folk medicine as analgesic, 
antiseptic, antispasmodic, antineuralgic, carminative, 
anti-inflammatory, disinfectant, insecticide, stimulant, 
stomachic, uterine and tonic14-15. Eugenol has been 
reported as antispasmodic and able to induce smooth 
muscle relaxation and vasorelaxation effects in diverse 
vascular beds18. Analgesic activity of Eugenol in dental 
medicine is mostly owing to inhibition of ion channels 
(Na+, K+ and Ca2+)19. Eugenol decreased the castor oil -
induced diarrhoea, Prostaglandin E2 (PGE2) induced 
fluid accumulation in intestines and tone of ileal smooth 
muscles and myometrium in rats20. Myogenic 
antispasmodic effect of Eugenol in rat airway smooth 
muscles contracted by electrical field stimulation (EFS) 
suggested that the mechanisms involved may be due to 
inhibition of voltage/receptor operated Ca2+ channels 
and IP3-receptor in the sarcoplasmic reticulum
21. 
Aqueous extracts of cloves (0.0625%) significantly 
decreased (95%) the normal activity of sodium-
potassium ATPase in rat liver22.  
 
Curcumin (diferuloylmethane) is a dietary 
polyphenolic, elicit plethora of health benefits, and 
alleviates various disease conditions such as malignant, 
neurodegenerative, cardiovascular diseases, 
inflammatory and neurological disorders. It is also used 
as an alternative therapy for uterine leiomyoma16,17. In 
these disease conditions, curcumin nanoparticles 
expressed greater therapeutic advantage over the native 
curcumin23. Modulatory role of curcumin on sodium –
potassium ATPase was described in human 
erythrocytes24, shark rectal glands, pig kidney25 and 
brain microsomes in rat26.  
 
Poor solubility, low systemic bioavailability and short 
half-life are the major problems associated in hindering 
the use of Curcumin in therapeutics. Synthesis of nano 
forms of curcumin emerged as an alternative to native 
curcumin. Studies have shown that nanocurcumin 
improved the bioavailability of the drug at the target site 
by enhanced permeability and retention (EPR) effect27. 
Recent reports suggested that nanocurcumin act as 
anticancer agent against neoplasticity in different 
organs28. It may be a promising lead for reducing 
hypertension. Administration of eugenol/curcumin in 
proper dose can reduce hypertension during pregnancy 
and this could be one of the potential adjuncts for 
treatment of pre-eclampsia. 
 
Information on the relative action of nutraceuticals on 
activation of Na+, K+-ATPase is almost lacking in any 
uterine artery. Therefore, the goal was to evaluate (i) the 
differences in KCl-induced vasorelaxation response 
(KVR) regulated by ouabain sensitive sodium pump and 
(ii) the effect of different nutraceuticals (Eugenol, 
Curcumin and Nanocurcumin) on the augmentation of 
KVR if any in UA of non-P and P goat. Our findings 
would provide first-hand information on the relative 
potential of Eugenol/Curcumin/Nanocurcumin- causing 
vasorelaxation in UA of NP and P and their influence on 
regulation of function of vascular Na+, K+-ATPase. 
 
Materials and Methods  
 
Ethical guidelines 
Ex vivo experimental protocol was approved from 
the Institutional Animal Ethical Committee with file 
no. 1586 (6)/16. 
 
Tissue preparation and isometric tension recording 
Non pregnant and pregnant uteri are collected from 
slaughter house in Modified Krebs-Henseleit Saline 
 
 
Fig. 2 — Structure and source of Curcumin 
 
 
Fig. 1 — Structure and source of Eugenol 




(MKHS) solution (mM): NaHCO3 11.9, NaCl 118, 
dextrose 11.1, MgSO4 1.2, KCl 4.7, KH2PO4 1.2, 
CaCl2 2.5 and pH 7.40. In the laboratory, the 
secondary branch of UA was cleaned carefully and 
dissected into circular arterial rings (1.5-2 mm). 
Individual arterial rings were clamped to an L-shaped 
stainless steel wire hooks and mounted in a 
thermostatically controlled (37.0±0.5ºC) 20 mL 
capacity tissue bath (Pan Lab) with basal tension of 
1.5 g. The bathing solution in the tissue bath was 
supplied with continuous bubbles of carbogenic 
mixture (95% O2+5% CO2). The arterial rings were 
superfused continuously with MKHS and bathing 
solution was replced every 15 min. The variation in 
net isometric contraction was recorded using high 
sensitive force transducer connected to 8/32 amplifier 
and analysed using Lab Chart 7.1.3 software. 
 
Experiments with Potassium-free modified KHS 
To assess the role of sodium pump in vascular 
endothelium, the arterial rings were equilibrated in the 
Pss for 1 hour and exposed to 5-HT (1.0 μM) to 
obtain a contraction. ACh (1μM) was added to bath to 
observe relaxation in UA rings pre-contracted with  
5-HT. The UA rings were then exposed to Pss for 30 
min and further the bath solution was replaced with 
potassium free MKHS solution to obtain a sustained 
contraction.  
Concentration related vasorelaxtion response to 
Potassium with or without Ouabain (1 μM) and 
Eugenol/Curcumin/Nanocurcumin (10 μM) was 
elicited in pre-contracted UA rings. 
The arterial ring was incubated in K+-free MKHS 
solution with or without Ouabain and Eugenol/ 
Curcumin/Nanocurcumin for 30 min. Subsequently, 
Potassium chloride was added (10 μM-10 mM) to the 
bath in a cumulative manner at an interval of 1 min to 
record the contractile response. The MUA rings were 
incubated with L-NAME (1 μM) before addition of 
KCl in order to eliminate the possible release of NO. 
 
Data analysis 
The data was indicated as Mean±SEM. The % 
maximum relaxation (Rmax/ RBmax) to Potassium 
(control/in the presence of other ligands) were 
calculated from net gram tension. Concentration 
related vasorelaxation curves were constructed and –
logIC50/pIC50 was analysed using interactive non-
linear regression with the help of Graph Pad Prism 5 
Software (USA). Statistical significance was set to 
p<0.05 and <0.001 for all experiments. 
 
Drugs 
Acetylcholine chloride, Ouabain and 5-hydroxy 
tryptamine, Eugenol and Curcumin were purchased 
from Sigma Chemicals Pvt Ltd. and one of the author 
Dr. Bimal P Mohanty gifted Nanocurcumin. Solutions 
were prepared using triple distilled water. Eugenol 
(99% purity) stock solution was prepared in dimethyl 
sulfoxide and Curcumin (>80% purity) prepared in 




Vasorelaxation to ACh in 5-HT (0.1 M) pre-contracted MUA 
rings. 
After 1 hr incubation with MKHS solution UA ring 
was contracted on exposure to 5-HT (0.1 μM). Further 
addition of ACh (1 μM) to the bath, the 5-HT- 
induced sustained contraction was inhibited the 
arterial contraction suggesting the presence of 
functional endothelium. 
 
Effect of Ouabain (1 μM) on KCl -induced vasorelaxation in 
MUA rings 
Table 1 presents Rmax and pIC50 of KCl-induced CRC 
in absence or presence  of  ouabain,  eugenol, curcumin, 
Table 1 — The Rmax (%)and pIC50 obtained from of K
+ (10 μM -10 mM) vasorelaxation response curve (control). The changes in RBmax 
and pIC50 of KVR curve with Ouabain, (1 μM) or Eugenol or Ouabain+Eugenol or Curcumin or Ouabain+Curcumin or Nanocurcumin or 
Ouabain+Nanocurcumin were listed. Each data level shows the Mean SEM, N= total number of data. 
TREATMENT  N Rmax/ RBmax (%) -LOG IC50 (pIC50) 
NP P  NP P  NP P 
KCl Control 6 6 6.90±0.55 26.58±2.07 3.47±0.06 3.79±0.06 
Ouabain 6 6 4.21±0.36b 4.87±0.55a 3.92±0.07a 3.81±0.04 
Eugenol 6 6 16.22±1.12a 42.67±0.55a 3.17±0.09b 2.59±0.09 a 
Ouabain+Eugenol 6 6 6.11±0.45 5.40±0.76a 3.83±0.04a 4.47±0.10 a 
Curcumin 6 6 21.23±0.22a 35.49±0.52b 2.60±0.06a 2.0±0.02 a 
Ouabain+Curcumin 6 6 9.18±1.14 3.39±0.10 a 3.94±0.05 a 3.87±0.05 
Nanocurcumin 6 6 6.91±0.35 34.58±0.25 b 1.53±0.29 a 2.43±0.08a 
Ouabain+Nanocurcumin 6 6 4.11±0.05a 6.00±0.66 a 2.94±0.04 a 2.57±0.11a 
a(p<0.001), b(p<0.05) shows values are significantly different from that of the control values within a particular column. 




Nanocurcumin or in combination with ouabain in UA of 
non-P and P goat. Representative raw traces showing 
effect of eugenol, curcumin and nanocurcumin on KCl-
induced contraction in Uterine arterial ring of both 
groups have been presented in Fig.3a-d. Addition of K+-
free solution to the bathing solution resulted a rise in 
basal tone in about 30 min and, subsequently, a 
sustained contraction was noticed in 3 min. Cumulative 
addition of KCl (10 μM–10 mM) inhibited sustained 
contraction in ED+MUA rings of NP and P Ch. KCl (10 
μM–10 mM) caused concentration related 
vasorelaxation (Rmax 6.90±0.55, pIC50 3.47±0.06%) in 
K+ free PSS precontracted MUA rings of NP Ch. 
Ouabain inhibited the vasorelaxation to KCl with 
rightward shift of VR curve by significant (p<0.05) 
decrease in RBmax (4.21±0.36%) and significant increase 
(p<0.001) in pIC50 (3.92±0.07). In uterine artery of P 
goat, KCl (10 μM–10 mM) caused concentration related 
vasorelaxation (Rmax 26.58±2.07%, pIC50 3.79±0.06) in 
K+ free PSS precontracted rings. In presence of Ouabain, 
there was rightward shift of KVR curve with significant 
(p<0.001) reduction of RBmax (4.87±0.55%) and non 
significant enhancement of pIC50 (3.81±0.04).  
 
Effect of Eugenol (10 μM) or Ouabain (1 μM) and Eugenol  
(10 μM) on KCl -induced vasorelaxation 
In presence of Eugenol (10 μM), VR to KCl was 
augmented with significant (p<0.001) increase in 
RBmax (16.22±1.12%) and (p<0.05) decrease in pIC50 
(3.17±0.09). In the presence of both Ouabain (1 μM) 
and Eugenol (10 μM), RBmax and pIC50 obtained from 
KVR curve were decreased (6.11±0.45%) and 
increased (3.83±0.04), respectively in MUA of NP Ch 
(Fig.4a). In MUA of P Ch, as observed from the KVR 
curve there was significant (p<0.001) increase in 
RBmax (42.67±0.55) and decrease in pIC50 (2.59±0.09) 
in presence Eugenol, decrease in RBmax (5.40±0.76%) 
and increase in pIC50 (4.47±0.10) in presence of both 
Ouabain and Eugenol as compared to the control 
(Fig.4b). 
 
Effect of Curcumin (10 μM) or Ouabain (1 μM) and Curcumin 
(10 μM) on KCl -induced vasorelaxation in MUA rings 
In non-pregnant goat, in presence of curcumin (10 
μM), there was rightward shift of KVR curve with 
significant (p<0.001) increase in RBmax (21.23±0.22%) 
and decrease in pIC50 (2.60±0.06), in presence of both 
ouabain (1 μM) and curcumin (10 μM) a non-
significant decrease in RBmax (9.18±1.14%) and 
significant (p<0.001) augmentation in pIC50 
(3.94±0.05) as compared to KVR (control) (Fig.5a). 
In uterine artery of P goat, the KVR was potentiated 
with significant (p<0.05) increase in RBmax 
(35.49±0.52) and decrease in pIC50 (2.0±0.02) in 
presence curcumin, was inhibited with significant 
(p<0.001) decrease in RBmax (3.39±0.10%) and non-
 
 
Fig. 3 — Representative raw traces showing effect in absence (Control, a) or in presence of 10 µM Eugenol (b), Curcumin (c) and 
Nanocurcumin (d) on KCl (10 µM-10 mM)-induced contraction in MUA ring of NP and P Ch groups. 




significant increase in pIC50 (3.87±0.05) with both 
ouabain and curcumin as compared to the KVR 
(control) (Fig. 5B). 
 
Effect of Nanocurcumin (10 μM) or Ouabain (1 μM) and 
Nanocurcumin (10 μM) on KCl -induced vasorelaxation in 
MUA rings. 
In MUA of nonpregnant goat, in presence of 
Nanocurcumin (10 μM), KVR curve was showed non-
significant increase in RBmax (6.91±0.35%) and 
significant (p<0.001) reduction in pIC50 (1.53±0.29). 
Similarly, in the presence of both ouabain (1 μM) and 
nanocurcumin (10 μM), it was significantly inhibited 
with reduction in RBmax (4.11±0.05%) and pIC50 
(2.94±0.04) (Fig. 6a). In uterine artery of P goat, the 
KVR was potentiated with increase in RBmax 
(34.58±0.25) and decrease in pIC50 (2.43±0.08) in 
presence nanocurcumin only, but it was significantly 
inhibited with decrease in RBmax (6.00±0.66%) and pIC50 
(2.57±0.11) in presence of both ouabain and 
nanocurcumin (Fig. 6b).  
 
Discussion 
The salient findings are (i) the Rmax obtained from 
KCl-response curve (KVR) elicited in uterine artery 
of non-pregnant (6.9%) and pregnant (26.58%) goat 
was reduced to 4.21% and 4.87% in presence of 
Ouabain, (ii) Eugenol, Curcumin and Nanocurcumin 
augmented the Rmax of KVR curve to 16.22%, 21.23% 
and 6.91% in UA of non-P goat and it was reversed to 
 
 
Fig. 4 — The effect of Ouabain (1 µM), Eugenol (10 µM), or in combination of Ouabain (1 µM) and Eugenol (10 µM) on KCl




Fig. 5 — KCl (10 µM-10 mM) vasorelaxation response curve constructed with Ouabain (1 µM), Curcumin (10 µM) or in combination of
Ouabain (1 µM) and Curcumin (10 µM) in uterine artery of a. NP (nonpregnant) and b. P (pregnant) goat. 




6.11%, 9.18% and 4.11% by Ouabain, (iii) these three 
polyphenols augmented the Rmax of VR curve of KCl 
to 42.67%, 35.49% and 34.58% and it was reversed to 
5.40%, 3.39% and 6.0% by Ouabain in uterine artery 
obtained from pregnant goat,suggesting their potential 
effect in modulating Na+, K+-ATPase.  
The function of Na+, K+-ATPase is critical in 
perpetuating the potential difference across the cell 
membrane and interim responsible for vascular tone 
and BP regulation3. In some arterial endothelium this 
ATPase has been considered as a factor causing 
cellular hyperpolarization designated as endothelium-
derived hyperpolarizing factor (EDHF)29. The 
objective of performing this functional study was to 
evaluate specifically the role of Ouabain sensitive 
Na+, K+-ATPase enzyme activity in inducing 
vasorelaxation in uterine artery by lower doses of K+. 
The function of this enzyme in maintaining vascular 
resistance and hypertension in rat renal artery30, 
thoracic aorta2, human placental vessels8, rabbit aorta9 
and, mice femoral artery10 has been reported.  
Three protein subunits of this -ATPase have been 
recognized in various tissues such as α, β and γ. In 
human tissues, four isoforms of α subunits (α1- α4) 
perform ATP hydrolysis and cation binding31, 
whereas three β subunit (β1-β3) maintains the 
stability and trafficking of the sodium pump32. In 
several mammalian cells, α subunits have greater 
affinity for inhibition by ouabain with notable 
exceptions, i.e., guinea pig small intestine33 and 
human cardiac muscle34 in which ouabain-resistant α 
subunits have been reported. In ovine mesenteric 
artery, α1 and α2 subunits of this enzyme exhibited 
low and high affinity to Ouabain12. In rat vascular 
tissues, the presence of alpha 1, alpha 2 and alpha 3 
subunit has been studied in mesenteric artery35, aorta 
myocytes36 and thoracic, superior mesenteric and tail 
arteries5 
Uterine contraction relies on the Na+, K+ -ATPase 
enzyme activity, which generates ionic gradient to 
induce excitation-contraction coupling. Differences in 
the alpha and beta isoforms of Na+, K+ -ATPase plays 
a vital role in pregnancy37. Alpha1 and beta1 subunits 
are universally present in tissues and their 
combination is termed as housekeeping form of Na+, 
K+ -ATPase38. Different isoforms of α subunits has 
been reported to be increased with increase in 
gestation period in rats. In pregnant rats, expression of 
Ouabain sensitive isoforms of sodium pump (α2 & α3) 
is increased but not α1
39. 
In our present study, the stability of sustained 
contraction was checked by 5-HT (0.1 μM) and 
relaxed with ACh (1 μM). ACh relaxed the 5HT 
precontracted rings signifying that MUA rings under 
experimentation has intact endothelium in both NP 
and P Ch. The maximal vasorelaxation obtained from 
KCl-response curve (KVR) elicited in MUA rings of 
was 6.9% and 26.58%, respectively. In presence of 
Ouabain the Rmax of KCl was reduced to 4.21% and 
4.87%. These results clearly show that in pregnant 
uterine artery the KVR is increased by 4.5 fold and 
ouabain reverses the Rmax of KVR in NP and P Ch to 
an identical percent. So our results specifically 




Fig. 6 — The effect of Ouabain (1 µM), Nanocurcumin (10 µM), or in combination of Ouabain (1 µM) and Nanocurcumin (10 µM) on
KCl (10 µM-10 mM) vasorelaxtion response curve of uterine artery of a. NP and b. P goat. 




(Ouabain sensitive) has (i) a minimal (<10%) 
contribution to vasodilation in uterine artery of NP, (ii) 
a significant increased activity in vasodilation of 
uterine artery of pregnant goat. The present findings 
clearly support our previous studies made in other 
vascular tissues of goat in which Ouabain sensitive 
Na+, K+-ATPase has been demonstrated to contribute 
differentially to vasorelaxation of ruminal artery13, 
mesenteric artery12 and middle uterine artery40.  
In order to assess the modulatory role of Eugenol on 
Na+, K+-ATPase in uterine vascular beds, KCl-induced 
vasorelaxation in K+-free PSS was elicited with 
Eugenol or Eugenol and Ouabain. Eugenol augmented 
the Rmax of KVR curve to16.22% and 42.67% in UA 
rings of non P and P goat, respectively. Ouabain almost 
completely reversed these Rmax of KVR curve to 6.11% 
and 5.40%. These results clearly indicate that (i) 
Ouabain sensitive Na+, K+-ATPase showed a minimal 
role in MUA of NP and its activity is increased by 
more than 4 fold in that of pregnant one, (ii) Eugenol 
activates the α1 subunit isoenzyme of Na
+, K+-ATPase 
in MUA by 2.4 fold in NP and 1.6 fold in P Ch as 
compared to their respective control (6.9% and 
26.58%). These results confirm that Eugenol activates 
α1-Na
+, K+-ATPase that contributes to vasorelaxation 
in MUA of NP and this is greatly increased in P Ch. 
Contradicting our findings, other findings 
demonstrated that Eugenol inhibited sodium pump in 
renal, intestinal, liver of rats and that could be due to 
reduced intracellular levels of ATP or defects in ion 
transport causing electrolyte imbalance and 
derangements in mitochondrial function22,41. As on 
today there are no reports on the vasodilator effect of 
Eugenol in uterine artery of goat affecting this ATPase 
function. A higher and moderate augmentation of KCl-
induced vasodilation by Eugenol in uterine artery of 
NP and P goat obtained from our findings clearly 
demonstrate that Eugenol increases the functional 
activity of α1 -Na
+, K+-ATPase (Ouabain sensitive) in a 
greater and lower proportion in uterine artery of non-
pregnant and pregnant goat, respectively. The possible 
underlying mechanism involved in augmented 
vasorelaxation to Eugenol in these tissues could be due 
to its enhanced phosphorylation of Na+, K+-ATPase as 
there is higher intracellular ATP level in these VSMCs.  
Curcumin increased the Rmax estimated from KVR 
curve elicited in uterine arterial rings of non-P (6.9%) 
and pregnant (26.58%) goat to 21.23% in NP and 
35.49% in P Ch. This demonstrated that Curcumin 
activates Na+, K+-ATPase more potently in P than that 
of NP Ch. Reversal of potentiating effect of Curcumin 
on KVR by Ouabain indicates that Curcumin augments 
the vasorelaxation effect via increased function of α1 is 
enzyme of Sodium ATPase. Interaction of Curcumin 
with Sodium pump has been reported to be biphasic in 
RBCs of human. In these tissues, Curcumin at 10-5M 
caused inhibition due to interaction with active 
catalytic sites and this resulted in down regulation of 
the enzyme. But it, at the concentration range of 10-7 -
10-8 M modulates RBC cell membrane fluidity and 
augments the function of Sodium potassium ATPase24. 
Curcumin efficacy and its interaction with sodium 
pump at protein-lipid interface mainly depends on 
membrane structure42. Curcumin augments Ouabain 
sensitive Na+, K+-ATPase by 3.07 and 1.33 fold in 
uterine artery of goat. Similarly, Nanocurcumin 
augmented the Rmax of KVR curve from 26.58% to 
34.58% in the pregnant UA rings but non-significantly 
in NP Ch. Ouabain and Nanocrucumin reduced the 
Rmax of KVR to 6% in UA rings of pregnant goat. 
These findings clearly demonstrate that Nanocurcumin 
increased Na+, K+-ATPase activity by 1.3 fold in P Ch 
but not in NP Ch. A greater and lower proportion 
increase in KCl-induced vasodilation by Curcumin in 
uterine artery of NP and P Ch clearly relates directly to 
a greater and lower sensitivity of α1 subunit isoenzyme 
of this ATPase to Curcumin. An identical sensitivity of 
α1 isoform of Sodium pump to Nanocurcumin was also 
observed in uterine artery of P but not in NP could not 
be explained with respect to underlying mechanisms as 
observed with Curcumin. 
In conclusion, the vascular resistance of UA of goat is 
maintained by low level function of Ouabain sensitive 
Sodium pump in non-pregnancy and this is greatly 
augmented in pregnancy which could be due to 
increased expression of α1 isoenzyme subunits. A greater 
sensitivity of Curcumin than Eugenol in activating Na+, 
K+-ATPase in non-pregnant rings could be occurring 
due to differences in the affinity of these polyphenols to 
interact with active catalytic canter of the enzyme or 
enhancing the ATP breakdown to increase Na+, K+-
ATPase function in non-P uterine artery as suggested in 
erythrocyte membranes. A greater sensitivity of Na+, K+-
ATPase for Eugenol than Curcumin or Nanocurcumin in 
pregnant rings may be resulted from increased function 
of α1isoenzyme subunits of Na
+-K+-ATPase that is 
differentially activated by these polyphenols.  
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